Microparticle Enhanced Cytotoxic Transarterial Embolization Therapy

NCT02694562 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
18
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Boston Scientific Corporation